SAN JOSE, Calif., April 10, 2018 -- Imanis Data, the leading provider of data orchestration, protection and mobility solutions for Big Data platforms, will be exhibiting at Couchbase Connect New York. Couchbase Connect is where Couchbase customers, partners and experts come to be inspired by the thought leaders who are radically transforming customer engagement, accelerating innovation and lowering infrastructure and operations costs with the world's first Engagement Database.
What: Executives will be present to give demos of Imanis Data’s platform and answer attendees’ questions, including on data masking for General Data Protection Regulation (GDPR) and Ransomware detection.
When: May 10, 2018
Where: Crowne Plaza, Times Square, New York City
Conference Participation: Attendees will be able to explore all Big Data customer use cases, including backup/recovery, cloud migration, compliance/data masking (e.g., GDPR), test data management and security (e.g., Ransomware).
About Imanis Data
Imanis Data is the leading provider of Big Data orchestration, mobility and protection for NoSQL and Hadoop. Our machine learning platform enables customers to fully monetize and secure their Big Data assets while improving both product development and quality. Our software optimizes storage tiering and disaster recovery, streamlines cloud migration and compliance such as Europe’s upcoming General Data Protection Regulation (GDPR) and rapidly identifies security threats such as Ransomware attacks. Imanis Data is located in San Jose, CA. For more information, visit http://imanisdata.com/.
FOR MORE INFORMATION, CONTACT:
Jessica Cheney
CommStrat for Imanis Data
419-350-4614
[email protected]


HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Mercer International Stock Surges 45% on C$20 Million Canada Funding
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Google Changes EU Spam Policy Amid Antitrust Scrutiny
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure
Toyota Global Sales Fall as China Demand Slumps
Jefferies Names AMEC Top China Semiconductor Equipment Pick
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 



